{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:15:27Z","timestamp":1724544927350},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ensci.2024.100512","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:48:42Z","timestamp":1718491722000},"page":"100512","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Acute Motor Conduction Block Neuropathy After Initiation of Omalizumab: Case Report and Literature Review for Possible Causality"],"prefix":"10.1016","volume":"36","author":[{"given":"Hosna S.","family":"Elshony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2024.100512_bb0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ensci.2024.100512_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02284784","article-title":"Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr\u00e9 syndrome","volume":"25","author":"Griffin","year":"1996","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.ensci.2024.100512_bb0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.61.5.617","article-title":"Acute motor conduction block neuropathy: another Guillain\u2013Barr\u00e9 syndrome variant","volume":"61","author":"Capasso","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ensci.2024.100512_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","article-title":"Approaches for identifying and defining environmentally associated rheumatic disorders","volume":"43","author":"Miller","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ensci.2024.100512_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5114\/ada.2018.74834","article-title":"Effects of omalizumab therapy on peripheral nerve functions: short observational study","volume":"36","author":"Yavuz","year":"2019","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.ensci.2024.100512_bb0030","first-page":"65","article-title":"Significance of conversation between mast cells and nerves","volume":"1","author":"Van der Kleij","year":"2005","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ensci.2024.100512_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/15569527.2021.1914076","article-title":"Effect of omalizumab treatment on peripheral nerves in patients with chronic spontaneous urticaria","volume":"40","author":"Altunisik","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ensci.2024.100512_bb0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s10067-006-0317-z","article-title":"Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment","volume":"26","author":"Tektonidou","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ensci.2024.100512_bb0045","first-page":"1018","article-title":"Neurological complications of infliximab","volume":"33","author":"Jarand","year":"2006","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.ensci.2024.100512_bb0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.ensci.2024.100512_bb0055","doi-asserted-by":"crossref","DOI":"10.1590\/S0004-282X2010000300022","article-title":"Motor neuropathy with multiple conduction blocks associated with TNF-alpha antagonist","volume":"68","author":"Carrilho","year":"2010","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ensci.2024.100512_bb0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10067-013-2272-9","article-title":"Severe Guillain-Barr\u00e9 syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review","volume":"32","author":"Alvarez-Lario","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ensci.2024.100512_bb0065","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar4582","article-title":"Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study","volume":"16","author":"Kaltsonoudis","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ensci.2024.100512_bb0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/rheumatology\/keh439","article-title":"Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy","volume":"44","author":"Rodriguez-Escalera","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.ensci.2024.100512_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"St\u00fcbgen","year":"2008","journal-title":"Muscle Nerve"}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650224000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650224000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T08:37:07Z","timestamp":1724488627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650224000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":15,"alternative-id":["S2405650224000194"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2024.100512","relation":{},"ISSN":["2405-6502"],"issn-type":[{"type":"print","value":"2405-6502"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Motor Conduction Block Neuropathy After Initiation of Omalizumab: Case Report and Literature Review for Possible Causality","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2024.100512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100512"}}